How many insider declarations has Rucci Carolyn M. filed?

Rucci Carolyn M. has filed 2 public insider declarations with SEC (Form 4).

What is Rucci Carolyn M.'s role?

Rucci Carolyn M.'s reported role is not specified by the regulator across the filings.

Which companies does Rucci Carolyn M. report trades for?

Rucci Carolyn M. reports trades for Akebia Therapeutics, Inc..

What is Rucci Carolyn M.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 20k€.

← Executives ★ Sign in to follow

RC

Rucci Carolyn M.

OFFICERF

·SEC (Form 4)

Akebia Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€19,762

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Rucci Carolyn M.. Director active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 2 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €20k. Activity tracked since 30 January 2026. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Rucci Carolyn M.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Akebia Therapeutics, Inc. (US)

申报2 总计

▼

Rucci Carolyn M.

SVP, Chief Legal Officer高管2026年2月2日Akebia Therapeutics, Inc.

US$23,41637SEC ↗

16,846 股@ US$1.39100.0% 占其流量Common StockSEC:0002107264-26-000006:0

◆

Rucci Carolyn M.

SVP, Chief Legal Officer高管2026年1月30日Akebia Therapeutics, Inc.

0SEC ↗

190,000 股0Common StockSEC:0002107264-26-000005:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RC

Rucci Carolyn M.

OFFICERF

·SEC (Form 4)

Akebia Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€19,762

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Rucci Carolyn M.. Director active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 2 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €20k. Activity tracked since 30 January 2026. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.